Trevena (NASDAQ:TRVN) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a report published on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Trevena Stock Performance NASDAQ:TRVN opened at $0.64 on Thursday. Trevena has a 1-year low of $0.51 and a 1-year high of $3.28. The company has a debt-to-equity […]